Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study)
Jerome Stirnemann, Jacques Serratrice, Tamara Mann, Pierre Louge, Combescure Christophe, Kaveh Samii, Rodrigue Pignel, Thomas Agoritsas, Marc Ansari, Giovanna Cannas, Yves Chalandon, Laurent Cimasoni, Pierre Cougoul, Benoit Desgraz, Alain Gervaix, Olivier Grosgurin, Thierry Joffre, Claude Lae, Marie-Anne Magnan, Etienne Menager, Annie Momo Bona, Marc-Alain Panchard, Michel Pellegrini, Jean-Luc Reny, Beatrice Riu, Cyril Sahyoun, Sylvain Boet
BMJ Open Nov 2024, 14 (11) e084825; DOI: 10.1136/bmjopen-2024-084825